Business Description
Oneness Biotech Co Ltd
ISIN : TW0004743000
Total Employee Number:
43Description
Oneness Biotech Co Ltd is engaged in the research and development of new drugs, the sale of pharmaceutical products and health products, and other related businesses. It focuses on developing drugs for the treatment of chronic skin and immune diseases. The Group's product portfolio comprises FESPIXON cream, for the treatment of diabetic foot ulcers, and Bonvadis, a wound care medical device. It also has various other product candidates in its development pipeline, such as FB825, FB704A, SNS812, SNS851, and others. The Group operates in the following reportable segments: New drug research and development, which derives maximum revenue, and the Agricultural products cultivation and organic food segment.
Financial Strength
6/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
Cash-To-Debt | 15.71 | |||||
Equity-to-Asset | 0.88 | |||||
Debt-to-Equity | 0.04 | |||||
Debt-to-EBITDA | -0.52 | |||||
Piotroski F-Score | 2/9 | |||||
Altman Z-Score | 12.58 | |||||
Beneish M-Score | -1.42 | |||||
WACC vs ROIC | ||||||
Growth Rank
2/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
3-Year Revenue Growth Rate | -50.8 | |||||
3-Year FCF Growth Rate | 21 | |||||
3-Year Book Growth Rate | -11.6 |
Momentum Rank
10/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
5-Day RSI | 28.79 | |||||
9-Day RSI | 37.71 | |||||
14-Day RSI | 42.13 | |||||
3-1 Month Momentum % | -12.59 | |||||
6-1 Month Momentum % | -32.55 | |||||
12-1 Month Momentum % | -26.16 |
Liquidity Ratio
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
Current Ratio | 11.81 | |||||
Quick Ratio | 11.6 | |||||
Cash Ratio | 11.17 | |||||
Days Inventory | 460.6 | |||||
Days Sales Outstanding | 67.62 | |||||
Days Payable | 8.37 |
Dividend & Buy Back
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
3-Year Average Share Buyback Ratio | -0.8 | |||||
Shareholder Yield % | -0.01 |
Profitability Rank
2/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
Gross Margin % | 30.88 | |||||
Operating Margin % | -618.85 | |||||
Net Margin % | -809.13 | |||||
EBITDA Margin % | -552 | |||||
FCF Margin % | -376.96 | |||||
OCF Margin % | -356.44 | |||||
ROE % | -9.47 | |||||
ROA % | -8.44 | |||||
ROIC % | -13.37 | |||||
3-Year ROIIC % | 34.97 | |||||
ROC (Joel Greenblatt) % | -88.59 | |||||
ROCE % | -8.62 | |||||
Years of Profitability over Past 10-Year | 1 |
GF Value Rank
4/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
PS Ratio | 180 | |||||
PB Ratio | 2.25 | |||||
Price-to-Tangible-Book | 2.49 | |||||
EV-to-EBIT | -17.18 | |||||
EV-to-EBITDA | -25.24 | |||||
EV-to-Revenue | 139.33 | |||||
EV-to-FCF | -42.48 | |||||
Price-to-GF-Value | 0.6 | |||||
Price-to-Projected-FCF | 16.25 | |||||
Price-to-Median-PS-Value | 0.22 | |||||
| Price-to-Net-Current-Asset-Value | 4.9 | |||||
| Price-to-Net-Cash | 5.27 | |||||
Earnings Yield (Greenblatt) % | -5.83 | |||||
FCF Yield % | -2.09 |
Operating Revenue by Business Segment
Operating Revenue by Geographic Region
Historical Operating Revenue by Business Segment
Historical Operating Revenue by Geographic Region
Guru Trades
See DetailsInsider Trades
See DetailsPeter Lynch Chart
Performance
Dividend
Log
Bar
Annualized Return % Â
Total Annual Return % Â
Oneness Biotech Co Ltd Executives
DetailsAnalyst Estimate
Key Statistics
| Name | Value | ||
|---|---|---|---|
| Revenue (TTM) (Mil NT$) | 129.123 | ||
| EPS (TTM) (NT$) | -2.18 | ||
| Beta | -0.9238 | ||
| 3-Year Sharpe Ratio | -1.41 | ||
| 3-Year Sortino Ratio | -1.51 | ||
| Volatility % | 34.74 | ||
| 14-Day RSI | 42.13 | ||
| 14-Day ATR (NT$) | 2.44903 | ||
| 20-Day SMA (NT$) | 51.9175 | ||
| 12-1 Month Momentum % | -26.16 | ||
| 52-Week Range (NT$) | 47.3 - 82.7 | ||
| Shares Outstanding (Mil) | 479.38 |
Piotroski F-Score Details
Year:
| Component | Result | ||
|---|---|---|---|
| Piotroski F-Score | 2 | ||
| Positive ROA | |||
| Positive CFROA | |||
| Higher ROA yoy | |||
| CFROA > ROA | |||
| Lower Leverage yoy | |||
| Higher Current Ratio yoy | |||
| Less Shares Outstanding yoy | |||
| Higher Gross Margin yoy | |||
| Higher Asset Turnover yoy |
Oneness Biotech Co Ltd Filings
| Filing Date | Document Date | Form | ||
|---|---|---|---|---|
| No Filing Data | ||||
Oneness Biotech Co Ltd Stock Events
| Event | Date | Price (NT$) | ||
|---|---|---|---|---|
| 1.04997:1 Stock Split | 2024-07-26 | 176.20 (+0.00%) | ||
| 1.1425:1 Stock Split | 2023-06-16 | 192.15 (-3.35%) | ||
| 1.09:1 Stock Split | 2015-08-24 | 23.02 (-2.27%) | ||
| 1.18:1 Stock Split | 2014-08-25 | 41.76 (+3.10%) | ||
| 1.1:1 Stock Split | 2012-09-06 | 12.90 (-1.74%) | ||
| 1.0449:1 Stock Split | 2011-10-13 | 10.57 (-2.27%) |
Show
Entries
Oneness Biotech Co Ltd Frequently Asked Questions
What is Oneness Biotech Co Ltd(ROCO:4743)'s stock price today?
The current price of ROCO:4743 is NT$48.60. The 52 week high of ROCO:4743 is NT$82.70 and 52 week low is NT$47.30.
When is next earnings date of Oneness Biotech Co Ltd(ROCO:4743)?
The next earnings date of Oneness Biotech Co Ltd(ROCO:4743) is .
Does Oneness Biotech Co Ltd(ROCO:4743) pay dividends? If so, how much?
Oneness Biotech Co Ltd(ROCO:4743) does not pay dividend.
Press Release
| Subject | Date | |||
|---|---|---|---|---|
| No Press Release | ||||
Articles on Oneness Biotech Co Ltd
No articles.
Survey
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
Follow Us
Disclaimers